Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon lambda 3 | 0.506 | 0.808 | 2.4E-08 |
|
disease | 0.400 | None | 0.976 | 592 | 5 | 2009 | 2020 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.400 | None | 0.986 | 136 | 0 | 1992 | 2019 | |||||||||
|
CD81 molecule | 0.555 | 0.846 | 0.92 |
|
disease | 0.400 | None | 0.947 | 101 | 1 | 1998 | 2020 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 0.960 | 99 | 2 | 1995 | 2019 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.400 | None | 0.839 | 31 | 1 | 2002 | 2019 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
disease | 0.400 | None | 0.969 | 31 | 5 | 1998 | 2020 | ||||||||
|
DExD/H-box helicase 58 | 0.526 | 0.808 | 1.8E-23 |
|
disease | 0.400 | None | 1.000 | 20 | 2 | 2007 | 2019 | ||||||||
|
scavenger receptor class B member 1 | 0.559 | 0.731 | 6.6E-02 |
|
disease | 0.400 | None | 1.000 | 11 | 0 | 2003 | 2018 | ||||||||
|
cytochrome P450 family 2 subfamily A member 6 | 0.556 | 0.731 | 5.4E-09 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 1997 | 2013 | ||||||||
|
cytochrome P450 family 3 subfamily A member 4 | 0.462 | 0.885 | 5.8E-11 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 1997 | 2019 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2007 | 2017 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2017 | ||||||||
|
lysyl oxidase like 2 | 0.527 | 0.731 | 3.4E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
microRNA 181c | 0.555 | 0.769 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2014 | 2020 | |||||||||
|
interferon lambda 4 (gene/pseudogene) | 0.670 | 0.577 |
|
disease | 0.200 | None | 0.952 | 83 | 4 | 2013 | 2020 | |||||||||
|
MER proto-oncogene, tyrosine kinase | 0.531 | 0.692 | 2.7E-11 |
|
disease | 0.120 | None | 1.000 | 2 | 2 | 2012 | 2017 | ||||||||
|
arginase 1 | 0.476 | 0.846 | 3.6E-04 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2009 | 2016 | ||||||||
|
reticulon 4 | 0.621 | 0.692 | 0.45 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2019 | ||||||||
|
G protein-coupled receptor 158 | 0.678 | 0.423 | 5.5E-04 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
disease | 0.100 | None | 0.931 | 420 | 2 | 1984 | 2020 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 0.973 | 374 | 1 | 1994 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 0.973 | 374 | 3 | 1994 | 2019 | |||||||||
|
progestagen associated endometrial protein | 0.430 | 0.846 | 3.1E-08 |
|
disease | 0.100 | None | 0.965 | 198 | 1 | 2000 | 2019 | ||||||||
|
vasoactive intestinal peptide receptor 1 | 0.573 | 0.654 | 7.4E-27 |
|
disease | 0.100 | None | 0.962 | 160 | 1 | 1992 | 2019 | ||||||||
|
endogenous retrovirus group K member 6, envelope | 0.521 | 0.808 |
|
disease | 0.100 | None | 1.000 | 118 | 0 | 1990 | 2019 |